Right Business: What does the future of microbiome treatments look like?

Money Matters with Hongbin Jeong and Chua Tian Tian

AMILI is a company at the forefront of microbiome research and healthcare innovation, aiming to help us reshape the way we think about our gut health.

As Asia’s first and only gut microbiome transplant bank, AMILI is on a mission to build the world’s largest multi-ethnic microbiome database, focusing specifically on the diverse populations of Southeast Asia.

On The Right Business, Hongbin Jeong speaks with Zat, Editor-in-Chief, The Peak Singapore to find out more.

See omnystudio.com/listener for privacy information.